Prolonged disease free survival with aggressive adjuvant chemotherapy in a case of large cell neuroendocrine carcinoma of the uterine cervix.
Markopoulos
M C
MC
Lagadas
A A
AA
Alexandrou
P
P
Giannakopoulos
K C
KC
Polyzos
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018287:Carcinoma, Large Cell / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy; D018278:Carcinoma, Neuroendocrine / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D018572:Disease-Free Survival; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy
D005047:Etoposide; D002945:Cisplatin